Are there patients with peritonitis who require empiric therapy for enterococcus?
about
Canadian practice guidelines for surgical intra-abdominal infectionsVancomycin-resistant enterococcal infections: epidemiology, clinical manifestations, and optimal managementVirulent synergistic effect between Enterococcus faecalis and Escherichia coli assayed by using the Caenorhabditis elegans model.A focus on intra-abdominal infections.Initial microbial spectrum in severe secondary peritonitis and relevance for treatment.A Comprehensive review of abdominal infections.Antimicrobial treatment of "complicated" intra-abdominal infections and the new IDSA guidelines ? a commentary and an alternative European approach according to clinical definitions.Essentials for selecting antimicrobial therapy for intra-abdominal infectionsDoes antibiotic selection impact patient outcome?Management of severe sepsis of abdominal origin.Antimicrobial treatment for intra-abdominal infections.Year in review 2009: Critical Care--infection.Intraabdominal infections in the intensive care unit.Ceftolozane/tazobactam (CXA 201) for the treatment of intra-abdominal infections.Clinical predictors for enterococcal bacteraemia in patients with bacteraemic intra-abdominal infections.Basis for selecting optimum antibiotic regimens for secondary peritonitis.Bad bacteria in acute appendicitis: rare but relevant.The open abdomen, indications, management and definitive closure.Emergence of spontaneous bacterial peritonitis due to enterococci - risk factors and outcome in a 12-year retrospective study.Changing trend in bile microbiology and antibiotic susceptibilities: over 12 years of experience.Clinical and bacteriological features and prognosis of ascitic fluid infection in Chinese patients with cirrhosis.
P2860
Q24599288-3DB215BB-9C43-4E68-B989-79DF6621A141Q26798630-970738F0-D1FB-43EE-B66B-E0C892CF7167Q33374802-99FF59EE-7163-4EAB-8510-A40D3660CD99Q33763449-73C6EC64-6F92-4B58-B65F-F025E488183FQ33975052-12253E56-F674-4A55-846E-9004DF2D8A90Q34626144-3B331877-6626-45A3-9BB2-4FE062048817Q35960005-F4D11884-4BFF-4077-9B19-564CE86F4443Q36649011-C70F92EE-FD1E-4FB4-BA5B-9DB02F9D42CFQ36672883-201C7CBB-65E5-4837-91EE-6EF709AE3F62Q36984156-EC3AC589-074A-448A-820A-81784344F576Q37000729-7D29696B-D295-48F4-8A5B-AF03D519E89AQ37814492-036E984E-056A-4C40-BF03-405A25531C8AQ38113473-7AA1BB79-6D02-47E7-B80B-A57D5366D591Q38241417-2CDB1036-D568-4858-83BC-FAE874C044D3Q38484309-4E17483C-45C9-4087-B1EA-9DF4860012FEQ38633450-7314B67A-68AC-4163-B778-389B891FD2CFQ38677990-7054A083-D893-4549-8331-14767AB065FDQ38980932-8947E614-83B6-4D3D-8047-5E9895E34E4DQ43770717-08D5466A-3B6B-4F7E-AA5A-F22CEDF7F114Q50894046-68534E67-4061-4422-B15B-E1741A6848E6Q55491656-B98BFEE2-4B6B-420A-8746-5D18D087F607
P2860
Are there patients with peritonitis who require empiric therapy for enterococcus?
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Are there patients with peritonitis who require empiric therapy for enterococcus?
@ast
Are there patients with peritonitis who require empiric therapy for enterococcus?
@en
type
label
Are there patients with peritonitis who require empiric therapy for enterococcus?
@ast
Are there patients with peritonitis who require empiric therapy for enterococcus?
@en
prefLabel
Are there patients with peritonitis who require empiric therapy for enterococcus?
@ast
Are there patients with peritonitis who require empiric therapy for enterococcus?
@en
P1476
Are there patients with peritonitis who require empiric therapy for enterococcus?
@en
P2093
P2888
P356
10.1007/S10096-003-1078-0
P577
2004-01-21T00:00:00Z